These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 23107586

  • 1. CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.
    Firpi RJ, Dong H, Clark VC, Soldevila-Pico C, Morelli G, Cabrera R, Norkina O, Shuster JJ, Nelson DR, Liu C.
    Liver Int; 2013 Jan; 33(1):72-8. PubMed ID: 23107586
    [Abstract] [Full Text] [Related]

  • 2. Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.
    Ackefors M, Nyström J, Wernerson A, Gjertsen H, Sönnerborg A, Weiland O.
    J Viral Hepat; 2013 Nov; 20(11):770-8. PubMed ID: 24168256
    [Abstract] [Full Text] [Related]

  • 3. Factors that predict response of patients with hepatitis C virus infection to boceprevir.
    Poordad F, Bronowicki JP, Gordon SC, Zeuzem S, Jacobson IM, Sulkowski MS, Poynard T, Morgan TR, Molony C, Pedicone LD, Sings HL, Burroughs MH, Sniukiene V, Boparai N, Goteti VS, Brass CA, Albrecht JK, Bacon BR, SPRINT-2 and RESPOND-2 Investigators.
    Gastroenterology; 2012 Sep; 143(3):608-618.e5. PubMed ID: 22626609
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
    Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, Poterucha JJ, Heimbach JK, Goldstein D, McHutchison J.
    Hepatology; 2011 Jan; 53(1):317-24. PubMed ID: 21254179
    [Abstract] [Full Text] [Related]

  • 5. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
    Lim KB, Sima HR, Fiel MI, Khaitova V, Doucette JT, Chernyiak M, Ahmad J, Bach N, Chang C, Grewal P, Kim-Schluger L, Liu L, Odin J, Perumalswami P, Florman SS, Schiano TD.
    World J Gastroenterol; 2015 May 28; 21(20):6236-45. PubMed ID: 26034358
    [Abstract] [Full Text] [Related]

  • 6. An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.
    Mangia A, Thompson AJ, Santoro R, Piazzolla V, Tillmann HL, Patel K, Shianna KV, Mottola L, Petruzzellis D, Bacca D, Carretta V, Minerva N, Goldstein DB, McHutchison JG.
    Gastroenterology; 2010 Sep 28; 139(3):821-7, 827.e1. PubMed ID: 20621700
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.
    Biggins SW, Trotter J, Gralla J, Burton JR, Bambha KM, Dodge J, Brocato M, Cheng L, McQueen M, Forman L, Chang M, Kam I, Everson G, Spritz RA, Klintmalm G, Rosen HR.
    J Hepatol; 2013 May 28; 58(5):969-76. PubMed ID: 23333445
    [Abstract] [Full Text] [Related]

  • 8. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
    Duarte-Rojo A, Veldt BJ, Goldstein DD, Tillman HL, Watt KD, Heimbach JK, McHutchison JG, Poterucha JJ, Vargas-Vorackova F, Charlton MR.
    Transplantation; 2012 Jul 27; 94(2):197-203. PubMed ID: 22766768
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
    Kawaoka T, Takahashi S, Takaki S, Hiramatsu A, Waki K, Hiraga N, Miki D, Tsuge M, Imamura M, Kawakami Y, Aikata H, Ochi H, Onoe T, Tashiro H, Ohdan H, Chayama K.
    J Gastroenterol Hepatol; 2012 Sep 27; 27(9):1467-72. PubMed ID: 22432893
    [Abstract] [Full Text] [Related]

  • 10. Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.
    Verna EC, Saxena V, Burton JR, O'Leary JG, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault NA, CRUSH-C Consortium.
    Transplantation; 2015 Aug 27; 99(8):1644-51. PubMed ID: 25715116
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-28B polymorphism in hepatitis C and liver transplantation.
    Duarte-Rojo A, Deneke MG, Charlton MR.
    Liver Transpl; 2013 Jan 27; 19(1):49-58. PubMed ID: 23008132
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
    Derbala M, Rizk N, Shebl F, Alkaabi S, Eldweik N, John A, Sharma M, Yaqoob R, Almohanadi M, Butt M, Alejji K.
    World J Gastroenterol; 2012 Dec 21; 18(47):7003-8. PubMed ID: 23323000
    [Abstract] [Full Text] [Related]

  • 13. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
    Eurich D, Boas-Knoop S, Ruehl M, Schulz M, Carrillo ED, Berg T, Neuhaus R, Neuhaus P, Neumann UP, Bahra M.
    Liver Transpl; 2011 Mar 21; 17(3):289-98. PubMed ID: 21384511
    [Abstract] [Full Text] [Related]

  • 14. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
    Mueller JL, King LY, Johnson KB, Gao T, Nephew LD, Kothari D, Simpson MA, Zheng H, Wei L, Corey KE, Misdraji J, Lee JH, Lin MV, Gogela NA, Fuchs BC, Tanabe KK, Gordon FD, Curry MP, Chung RT.
    Clin Transplant; 2016 Apr 21; 30(4):452-60. PubMed ID: 26854475
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.
    Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, Urban T, Afdhal NH, Jacobson IM, Esteban R, Poordad F, Lawitz EJ, McCone J, Shiffman ML, Galler GW, Lee WM, Reindollar R, King JW, Kwo PY, Ghalib RH, Freilich B, Nyberg LM, Zeuzem S, Poynard T, Vock DM, Pieper KS, Patel K, Tillmann HL, Noviello S, Koury K, Pedicone LD, Brass CA, Albrecht JK, Goldstein DB, McHutchison JG.
    Gastroenterology; 2010 Jul 21; 139(1):120-9.e18. PubMed ID: 20399780
    [Abstract] [Full Text] [Related]

  • 16. Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.
    Kamal SM, Kassim SK, Ahmed AI, Mahmoud S, Bahnasy KA, Hafez TA, Aziz IA, Fathelbab IF, Mansour HM.
    Am J Gastroenterol; 2014 Feb 21; 109(2):199-211. PubMed ID: 24445571
    [Abstract] [Full Text] [Related]

  • 17. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
    Cieśla A, Bociąga-Jasik M, Sobczyk-Krupiarz I, Głowacki MK, Owczarek D, Cibor D, Sanak M, Mach T.
    World J Gastroenterol; 2012 Sep 21; 18(35):4892-7. PubMed ID: 23002361
    [Abstract] [Full Text] [Related]

  • 18. Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation.
    Graziadei IW, Zoller HM, Schloegl A, Nachbaur K, Pfeiffer KP, Mark W, Mikuz G, Pratschke J, Margreiter R, Vogel W.
    Liver Transpl; 2012 Jun 21; 18(6):671-9. PubMed ID: 22298465
    [Abstract] [Full Text] [Related]

  • 19. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
    Lange CM, Moradpour D, Doehring A, Lehr HA, Müllhaupt B, Bibert S, Bochud PY, Antonino AT, Pascual M, Farnik H, Shi Y, Bechstein WO, Moench C, Hansmann ML, Sarrazin C, Lötsch J, Zeuzem S, Hofmann WP.
    J Hepatol; 2011 Aug 21; 55(2):322-7. PubMed ID: 21147186
    [Abstract] [Full Text] [Related]

  • 20. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
    Konishi H, Motomura T, Matsumoto Y, Harimoto N, Ikegami T, Yoshizumi T, Soejima Y, Shirabe K, Fukuhara T, Maehara Y.
    J Viral Hepat; 2014 Jun 21; 21(6):397-404. PubMed ID: 24750545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.